First Quadrant’s Collegium Pharmaceutical COLL Stock Holding History

First Quadrant’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-16,267	Closed	-$266K	–	735
2020 Q1	$266K	Sell	16,267 -10,220	-39%	-$211K	0.04%	361
2019 Q4	$545K	Buy	+26,487	New	+$441K	0.05%	306
2019 Q3	–	Sell	-4,484	Closed	-$59K	–	602
2019 Q2	$59K	Buy	4,484 +2,089	+87%	+$27.9K	﹤0.01%	621
2019 Q1	$36K	Buy	+2,395	New	+$38.4K	﹤0.01%	657

Other funds holding COLL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

First Quadrant's COLL Position: Q2 2020 in Review

First Quadrant sold out of Collegium Pharmaceutical (COLL) in Q2 2020, closing a stake of 16,267 shares — an estimated $266K sold.

First Quadrant first reported a position in COLL in Q1 2019 and held it in 4 quarters. The position peaked at $545K in Q4 2019. 150 funds tracked by Wall St. Rank hold COLL as of Q2 2020.

First Quadrant reported no remaining Collegium Pharmaceutical position as of Q2 2020 after selling out during the quarter.
First Quadrant sold 16,267 Collegium Pharmaceutical shares in Q2 2020, an estimated $266K.
First Quadrant first reported a position in Collegium Pharmaceutical in Q1 2019 and held it in 4 quarters.
First Quadrant's Collegium Pharmaceutical position peaked at $545K in Q4 2019.
150 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2020.

Based on First Quadrant's 13F filing for Q2 2020, filed 28 Jul 2020.